Apollo Hospitals Group collaborates with Tata Medical and Diagnostics

20 Nov 2020 Evaluate

Apollo Hospitals Group has collaborated with Tata Medical and Diagnostics (TataMD) to introduce 'TataMD CHECK' diagnostic test for COVID-19 in the country, which will provide faster results. Apollo Hospitals along with its subsidiary Apollo Diagnostics will offer the Tata MD CHECK testing in the national capital region (NCR) from the first week of December 2020 and thereafter, it will be rolled out across all major metros in the country.

TataMD CHECK is a COVID-19 diagnostic test based on the DNA genome editing tool CRISPR Cas-9 and has been approved by Indian Council of Medical Research and Drug Controller General of India (DCGI).  The use of CRISPR-Cas9 Technology ensures quicker results due to a more agile process and AI-based automated result detection methodology.

Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, etc.

Apollo Hospital Ent. Share Price

7189.25 -9.10 (-0.13%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×